UK markets closed

Hutchison China MediTech Limited (HCM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.860.00 (0.00%)
At close: 04:00PM EDT
14.55 +0.69 (+4.98%)
After hours: 05:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.38B
Enterprise value 1.55B
Trailing P/E 17.69
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.90
Price/book (mrq)3.00
Enterprise value/revenue 3.87
Enterprise value/EBITDA -5.96

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-65.23%
S&P500 52-week change 3-4.45%
52-week high 342.93
52-week low 38.40
50-day moving average 312.45
200-day moving average 321.30

Share statistics

Avg vol (3-month) 3622.06k
Avg vol (10-day) 3304.83k
Shares outstanding 5172.92M
Implied shares outstanding 6N/A
Float 888M
% held by insiders 10.41%
% held by institutions 131.47%
Shares short (28 Jul 2022) 42.7M
Short ratio (28 Jul 2022) 47.25
Short % of float (28 Jul 2022) 4N/A
Short % of shares outstanding (28 Jul 2022) 41.56%
Shares short (prior month 29 Jun 2022) 42.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -63.65%
Operating margin (ttm)-95.14%

Management effectiveness

Return on assets (ttm)-19.32%
Return on equity (ttm)-24.72%

Income statement

Revenue (ttm)400.81M
Revenue per share (ttm)2.35
Quarterly revenue growth (yoy)33.30%
Gross profit (ttm)-201.19M
EBITDA -373.29M
Net income avi to common (ttm)-255.11M
Diluted EPS (ttm)-1.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)829.71M
Total cash per share (mrq)4.91
Total debt (mrq)418k
Total debt/equity (mrq)0.05
Current ratio (mrq)3.18
Book value per share (mrq)4.74

Cash flow statement

Operating cash flow (ttm)-222.76M
Levered free cash flow (ttm)-161.87M